SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1876)4/2/1998 11:06:00 AM
From: Joe Wesley  Respond to of 4676
 
Hi Miljenko:

Thanks for the link.

Maybe we should work on a strategy to redefine Isis as an internet company. They have enough revenues to have a $4 Billion cap.

Amateur



To: Miljenko Zuanic who wrote (1876)4/2/1998 7:35:00 PM
From: Perry  Read Replies (1) | Respond to of 4676
 
Anyone have any information or idea when phase III clinical trials for ISIS 2302 for Crohn's disease will finish? How large is this market (i.e. how many people suffer from this disease?)

Thanks in advance,
Perry


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News